Primary: 90-day postoperative mortality. 30-day postoperative infection rate. Secondary: early allograft dysfunction (EAD), bilirubin, AST/ALT, INR. Pre-transplant MELD/CTP scores, fecal microbiota changes. This evidence concerns the gene GPT and infection.